Woodford investors endure ‘another kick in the teeth’ as Synairgen quintuples
Biotech holding soars 550% one month after Link sold it on the cheap to Acacia Research
Synairgen
-
-
Link sells Woodford stock surging more than tenfold amid coronavirus outbreak
Synairgen has begun its first trial on patients for a respiratory drug to treat Covid-19
-
Sports Direct posts 67% lower profits; mixed bag for Woodford picks
Thursday was a day of dramatic share price swings as Sports Direct’s profits more than halved and markets digested big announcements from two Neil Woodford-backed firms.